乳腺癌抗雌激素耐药蛋白1

参考价:¥1
供货周期: 现货
品牌: 康朗生物
规格: 0.1ml/0.2ml
货号: KL6223R
CAS号:
上海康朗生物科技有限公司
银牌会员9年生产商
关注展位 全部试剂
产品详情

?乳腺癌抗雌激素耐药蛋白1Quantity size:

0.2ml

Concentration:

1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

p130 represents one of several known substrates for v-Crk encoded p47. p130 Cas (for Crk-associated substrate) exhibits a high level of tyrosine phosphorylation and is tightly associated with v-Crk, 乳腺癌抗雌激素耐药蛋白1suggesting a role in v-Crk-mediated cell signaling. The molecular cloning of p130 Cas has shown it to represent a novel SH3 containing signaling molecule with a cluster of multiple putative SH2-binding motifs for v-Crk. By immunoprecipitation analysis, p130 Cas has been shown to be highly phosphorylated at tyrosine residues subsequent to either v-Src p60 or v-Crk-mediated transformation and to form stable complexes with both of these transforming proteins. 乳腺癌抗雌激素耐药蛋白1p130 Cas behaves as an extremely potent substrate for protein tyrosine kinases and has been reported to relocate from the cytoplasm to cell membrane upon tyrosine phosphorylation. One proposed model is that the SH2 domain of v-Crk functions to activate c-Src kinase, which in turn phosphorylates p130 Cas.

Also known as:

乳腺癌抗雌激素耐药蛋白1Breast cancer anti estrogen resistance 1 protein; BCAR 1; Bcar1; BCAR1_HUMAN; Breast cancer anti estrogen resistance 1; Breast cancer anti-estrogen resistance protein 1; CAS; Cas scaffolding protein family member 1; Crk associated substrate; Crk associated substrate p130Cas; CRK-associated substrate; CRKAS; P130CAS.

Specificity:

Rabbit Polyclonal IgG, affinity purified by Protein A.

Reacts with: Human, Mouse, Rat, Dog, Cow, Rabbit, .

Immunogen: KLH conjugated synthetic peptide derived from human BCAR1.

乳腺癌抗雌激素耐药蛋白1Predicted Molecular Weight: 93kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl054Eq01胰岛素样生长因子结合蛋白3(IGFBP3)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 3 (IGFBP3)

kl054Fi01胰岛素样生长因子结合蛋白3(IGFBP3)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 3 (IGFBP3)

kl054Ga01胰岛素样生长因子结合蛋白3(IGFBP3)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 3 (IGFBP3)

kl054Hu01胰岛素样生长因子结合蛋白3(IGFBP3)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 3 (IGFBP3)

kl054Mu01胰岛素样生长因子结合蛋白3(IGFBP3)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 3 (IGFBP3)

kl054Po01胰岛素样生长因子结合蛋白3(IGFBP3)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 3 (IGFBP3)

kl054Ra01胰岛素样生长因子结合蛋白3(IGFBP3)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 3 (IGFBP3)

kl055Bo01胰岛素样生长因子结合蛋白4(IGFBP4)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 4 (IGFBP4)

kl055Cp01胰岛素样生长因子结合蛋白4(IGFBP4)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 4 (IGFBP4)

kl055Ga01胰岛素样生长因子结合蛋白4(IGFBP4)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 4 (IGFBP4)

kl055Hu01胰岛素样生长因子结合蛋白4(IGFBP4)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 4 (IGFBP4)

kl055Mu01胰岛素样生长因子结合蛋白4(IGFBP4)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 4 (IGFBP4)

kl055Po01胰岛素样生长因子结合蛋白4(IGFBP4)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 4 (IGFBP4)

kl056Bo01白介素10(IL10)多克隆抗体Polyclonal Antibody to Interleukin 10 (IL10)

kl056Ca01白介素10(IL10)多克隆抗体Polyclonal Antibody to Interleukin 10 (IL10)

kl056Cp01白介素10(IL10)多克隆抗体Polyclonal Antibody to Interleukin 10 (IL10)


乳腺癌抗雌激素耐药蛋白1信息由上海康朗生物科技有限公司为您提供,如您想了解更多关于乳腺癌抗雌激素耐药蛋白1报价、型号、参数等信息, 欢迎来电或留言咨询。除供应乳腺癌抗雌激素耐药蛋白1外,上海康朗生物科技有限公司还可为您提供乳腺癌增强蛋白2抗体、人乳腺癌易感蛋白2检测试剂盒等产品, 公司有专业的客户服务团队,是您值得信赖的合作伙伴。

相关试剂 更多

相关产品

当前位置: 仪器信息网 康朗生物 试剂 乳腺癌抗雌激素耐药蛋白1

关注

拨打电话

留言咨询